PharmEcosse is a UK-based clinical-stage company progressing a novel therapeutic program that has the potential to become standard of care in the reduction and prevention of surgical scars.
For further information on becoming a clinical trial volunteer, please contact:
Clinical Trials Unit
PharmEcosse Ltd
Greendykes Steading
Edzell
Brechin
DD9 7UY
T +44 1356 648941
Edzell, 7th February 2011 - PharmEcosse Ltd has received approval for a Phase 2 clinical study to explore the use of PE001 for the reduction or prevention of surgical scars in patients undergoing non-cancer bilateral breast surgery. The trial will commence in January 2011 and is expected to report in the first quarter of 2013.
